Related Experiment Video
Updated: Jan 11, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Medical Assistance in Dying in Canada: A Review for Canadian Dermatologists
Celina DeBiasio1,2, Stefanie Green3,4, Mark G Kirchhof1,2
1Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Abstract:
Medical assistance in dying (MAiD) is an end-of-life care option legally available across Canada for individuals with a "grievous and irremediable condition." For patients in dermatology, particularly those with aggressive skin cancers, the physical and psychological toll of their conditions can be profound. As MAiD becomes increasingly integrated into Canadian healthcare, some dermatologists may be consulted by medical teams for their expertise in complex dermatologic conditions in patients who are considering end-of-life care options. Since MAiD has been legalized across Canada, it is important for healthcare practitioners in Canada, including dermatologists, to have a basic understanding of the legal and ethical considerations within a Canadian context. This manuscript reviews MAiD within the Canadian healthcare landscape. It briefly reviews the legal framework in Canada, ethical considerations, and the potential evolving role of dermatologists as "disease consultants."
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Ethical Dilemmas II
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Ethical Issues
Ethical Concerns in Healthcare:
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

